Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

257 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[A 56-year-old man with fever and backache persisting for 6 months].
Kageyama S, Iguchi M, Omagari N, Tsurumi H, Takagi T, Sato M, Fujimoto H, Ushida S, Yasui M, Kanematsu T, Imaizumi T, Suzuki T, Hakamada Y, Ishizuka T, Kusafuka H. Kageyama S, et al. Among authors: tsurumi h. Nihon Naika Gakkai Zasshi. 2009 Aug 10;98(8):2023-30. doi: 10.2169/naika.98.2023. Nihon Naika Gakkai Zasshi. 2009. PMID: 19899228 Japanese. No abstract available.
Hemarthrosis in a patient with abdominal aortic aneurysm.
Tsurumi H, Yano H, Kinjo M. Tsurumi H, et al. Am J Med. 2024 Apr 20:S0002-9343(24)00247-X. doi: 10.1016/j.amjmed.2024.04.013. Online ahead of print. Am J Med. 2024. PMID: 38648997 No abstract available.
The pretreatment Controlling Nutritional Status score is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma.
Kaneda Y, Kanemura N, Nakamura N, Ikoma Y, Yamaguchi K, Takada E, Shibata Y, Lee S, Fujita K, Morishita T, Matsumoto T, Nakamura H, Kitagawa J, Kasahara S, Hara T, Tsurumi H, Shimizu M. Kaneda Y, et al. Among authors: tsurumi h. Leuk Lymphoma. 2024 Mar;65(3):339-345. doi: 10.1080/10428194.2023.2295787. Epub 2023 Dec 20. Leuk Lymphoma. 2024. PMID: 38124378
A phase II study of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed or refractory non-Hodgkin lymphoma.
Ikoma Y, Nakamura N, Kitagawa J, Miwa T, Takada E, Matsumoto T, Shibata Y, Nakamura H, Kanemura N, Kasahara S, Hara T, Sawada M, Tsurumi H, Shimizu M. Ikoma Y, et al. Among authors: tsurumi h. Hematol Oncol. 2024 Jan;42(1):e3236. doi: 10.1002/hon.3236. Epub 2023 Nov 6. Hematol Oncol. 2024. PMID: 37932900 Clinical Trial.
Comparison of the prognostic impact of IPI and PIT in peripheral T-cell lymphoma in real-world practice with a large elderly population.
Nakamura N, Kanemura N, Matsumoto T, Nakamura H, Ikoma Y, Shibata Y, Kitagawa J, Kasahara S, Yamada T, Sawada M, Kaneda Y, Fukuno K, Takada E, Goto H, Lee S, Fujita K, Morishita T, Hara T, Tsurumi H, Shimizu M. Nakamura N, et al. Among authors: tsurumi h. Sci Rep. 2023 Nov 4;13(1):19060. doi: 10.1038/s41598-023-46501-5. Sci Rep. 2023. PMID: 37925551 Free PMC article.
257 results